Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             88 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 A case of possible atypical demyelinating event of the central nervous system following COVID-19 Zoghi, Anahita

44 C p.
artikel
2 Acquired hemophilia A and other autoimmune diseases after alemtuzumab therapy for multiple sclerosis: A report of two cases Comini-Frota, Elizabeth R.

44 C p.
artikel
3 Age at onset correlate with disability in Latin American aquaporin-4-IgG-positive NMOSD patients Carnero Contentti, Edgar

44 C p.
artikel
4 A new paraplegin mutation in a patient with primary progressive multiple sclerosis Bellinvia, Angelo

44 C p.
artikel
5 An investigation of knee position sense, balance, and dual task performance in different phases of menstrual cycle in females with multiple sclerosis: a pilot study ATEŞ, Yasemin

44 C p.
artikel
6 An overview of lipidomic analysis in different human matrices of multiple sclerosis Ferreira, Helena Beatriz

44 C p.
artikel
7 Anti-MOG and Anti-AQP4 positive neuromyelitis optica spectrum disorder in a patient with myasthenia gravis Bates, Molly

44 C p.
artikel
8 Anti-myelin oligodendrocyte glycoprotein (MOG) associated disease masquerading as prolonged intractable nausea and vomiting Block, Allison

44 C p.
artikel
9 Anxiety and depression in Multiple Sclerosis (MS): Antecedents, consequences, and differential impact on well-being and quality of life Hanna, Mariam

44 C p.
artikel
10 Attenuation of antibody response to SARS-CoV-2 in a patient on ocrelizumab with hypogammaglobulinemia Conte, William L

44 C p.
artikel
11 Atypical MOG antibody disease presenting with typical multiple sclerosis lesions Dolbec, Katelyn

44 C p.
artikel
12 Balo's concentric sclerosis: An atypical demyelinating disease in pediatrics Arenas Vargas, Laura Estefanía

44 C p.
artikel
13 Biotinidase deficiency in differential diagnosis of neuromyelitis optica spectrum disorder Bilge, Nuray

44 C p.
artikel
14 Can multiple sclerosis be cured? A case of highly active relapsing multiple sclerosis treated with autologous hematopoietic stem-cell transplantation 13 years ago Lycke, Jan

44 C p.
artikel
15 Cannabis extract for the treatment of painful tonic spasms in a patient with neuromyelitis optica spectrum disorder: A case report Tisavipat, Nanthaya

44 C p.
artikel
16 Cerebral hemodynamics in patients with multiple sclerosis Lattanzi, Simona

44 C p.
artikel
17 Change in pregnancy-associated multiple sclerosis relapse rates over time: a meta-analysis Dobson, Ruth

44 C p.
artikel
18 Characteristic of gut microbiota in southeastern Chinese patients with neuromyelitis optica spectrum disorders Zhang, Juan

44 C p.
artikel
19 Clinical and radiological profile of neuromyelitis optica spectrum disorders in an Ecuadorian cohort Edgar Patricio, Correa-Díaz

44 C p.
artikel
20 Coffee consumption is not associated with risk of multiple sclerosis: A Mendelian randomization study Lu, Hui

44 C p.
artikel
21 Co-incident primary progressive multiple sclerosis and hereditary spastic paraplegia (SPG4) – a case report Boucher, John J

44 C p.
artikel
22 Connection of miR-185 and miR-320a expression levels with response to interferon-beta in multiple sclerosis patients Mousavi, Seyyed Reza

44 C p.
artikel
23 Conversion of clinically isolated syndrome to multiple sclerosis: a prospective study Kolčava, Jan

44 C p.
artikel
24 Covid-19 in a patient with multiple sclerosis treated with natalizumab: May the blockade of integrins have a protective role? Aguirre, Clara

44 C p.
artikel
25 COVID-19 in 7 multiple sclerosis patients in treatment with ANTI-CD20 therapies Meca-Lallana, Virginia

44 C p.
artikel
26 COVID-19 prevention and multiple sclerosis management: The SAFE pathway for the post-peak Buonomo, Antonio

44 C p.
artikel
27 Cryptogenic cerebral venous thrombosis in a multiple-sclerosis-patient treated with Alemtuzumab Gasparini, Sara

44 C p.
artikel
28 Current and emerging therapeutics for neuromyelitis optica spectrum disorder: Relevance to the COVID-19 pandemic Abboud, Hesham

44 C p.
artikel
29 Decision-making on management of ms and nmosd patients during the COVID-19 pandemic: A latin american survey Ricardo, Alonso

44 C p.
artikel
30 Do you believe in Gad? Maghzi, A.-H.

44 C p.
artikel
31 Dysregulation of microRNAs regulating survivin in CD4+ T cells in multiple sclerosis Alizadeh-Fanalou, Shahin

44 C p.
artikel
32 Effects of a 10-week multimodal dance and art intervention program leading to a public performance in persons with multiple sclerosis - A controlled pilot-trial Van Geel, Fanny

44 C p.
artikel
33 Epidemiology of pediatric multiple sclerosis: A systematic literature review and meta-analysis Yan, Kevin

44 C p.
artikel
34 Establishment of a safety protocol for the administration of treatments in multiple sclerosis during the SARS-CoV-2 pandemic Meca-Lallana, Virginia

44 C p.
artikel
35 Estimating the risk of COVID-19 in multiple sclerosis patients in Buenos Aires, Argentina Cristiano, E

44 C p.
artikel
36 Evaluation of COVID-19 infection in patients with Neuromyelitis optica spectrum disorder (NMOSD): A report from Iran Sahraian, Mohammad Ali

44 C p.
artikel
37 Evolution of tongue somatosensory evoked potentials in people with multiple sclerosis Krbot Skorić, Magdalena

44 C p.
artikel
38 Familial clustering of neuromyelitis optica and multiple sclerosis: clues pointing towards shared risks? Bonnan, Mickael

44 C p.
artikel
39 FLAIR-hyperintense Lesions in Anti-MOG-associated Encephalitis With Seizures (FLAMES): Is immunotherapy always needed to put out the fire? Budhram, Adrian

44 C p.
artikel
40 Frequency and severity of COVID-19 in multiple sclerosis: A short single-site report from northern Italy Crescenzo, Francesco

44 C p.
artikel
41 Functional recovery in multiple sclerosis patients undergoing rehabilitation programs is associated with plasma levels of hemostasis inhibitors Ziliotto, Nicole

44 C p.
artikel
42 Highly sensitive quantification of optic neuritis intrathecal biomarker CXCL13 Olesen, M.N.

44 C p.
artikel
43 Impact of multiple sclerosis risk loci in postinfectious neurological syndromes Martinelli-Boneschi, Filippo

44 C p.
artikel
44 Incidence, prevalence and characteristics of MS in São Miguel, an island in the Atlantic Lopes, Pedro

44 C p.
artikel
45 Interferon Beta-1a Cardiomyopathy in a Patient with Multiple Sclerosis: Case Report Cheraghmakani, H.

44 C p.
artikel
46 Intravenous immunoglobulin for acute attacks in neuromyelitis optica spectrum disorders (NMOSD) Li, Xindi

44 C p.
artikel
47 Is serological response to SARS-CoV-2 preserved in MS patients on ocrelizumab treatment? A case report Lucchini, Matteo

44 C p.
artikel
48 Large hemispheric lesions in autoimmune encephalitis associated with anti-GAD 65 antibodies Sianati, Bahareh

44 C p.
artikel
49 Management of Idiopathic CNS inflammatory diseases during the COVID-19 pandemic: Perspectives and strategies for continuity of care from a South East Asian Center with limited resources. Viswanathan, S.

44 C p.
artikel
50 Measuring the health-related quality of life in Australians with multiple sclerosis using the assessment of quality of life-8-dimension (AQoL-8D) multi-attribute utility instrument Ahmad, Hasnat

44 C p.
artikel
51 Mesenchymal stem cells in experimental autoimmune encephalomyelitis model of multiple sclerosis: A systematic review and meta-analysis Yanwu, Yang

44 C p.
artikel
52 Metabolic syndrome components and disease disability in egyptian multiple sclerosis patients Fahmi, Rasha M.

44 C p.
artikel
53 Mild COVID-19 infection despite chronic B cell depletion in a patient with aquaporin-4-positive neuromyelitis optica spectrum disorder. Creed, Marina A.

44 C p.
artikel
54 Mild COVID-19 infection in a patient with multiple sclerosis and severe depletion of T-lymphocyte subsets due to alemtuzumab Guevara, Carlos

44 C p.
artikel
55 Mitoxantrone in relapsing-remitting and rapidly progressive multiple sclerosis: Ten-year clinical outcomes post-treatment with mitoxantrone Foo, E.C.

44 C p.
artikel
56 Mortality trend for multiple sclerosis in Italy during the period 1980–2015 Bezzini, Daiana

44 C p.
artikel
57 Multiple sclerosis and neuromyelitis optica after optic neuritis: A nationwide cohort study in Taiwan Lin, Wei-Sheng

44 C p.
artikel
58 Multiple sclerosis coverage in the written media of a low prevalence country Cárdenas-Robledo, Simón

44 C p.
artikel
59 Myelin oligodendrocyte glycoprotein antibody associated central nervous system demyelinating disease: a tertiary center experience from Turkey Inan, Berin

44 C p.
artikel
60 Negative SARS-CoV-2 antibody testing following COVID-19 infection in Two MS patients treated with ocrelizumab Thornton, Jeanine Rempe

44 C p.
artikel
61 Neurourological assessment in people with multiple sclerosis (MS): a new evaluated algorithm Domurath, Burkhard

44 C p.
artikel
62 Normative values of the Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS) in an Arab population: Corrected for age, sex and education Alboudi, Ayman

44 C p.
artikel
63 Optic neuropathy: A 15-year retrospective observational study Alves, José Miguel

44 C p.
artikel
64 Outcomes and future directions for neuroimmunology/multiple sclerosis fellowship training: Survey of recent trainees Hua, Le H.

44 C p.
artikel
65 Patients' perspective and usability of innovation technology in a new rehabilitation pathway: An exploratory study in patients with multiple sclerosis Manuli, Alfredo

44 C p.
artikel
66 Potential COVID-19 infection in patients with severe multiple sclerosis treated with alemtuzumab Matías-Guiu, Jorge

44 C p.
artikel
67 Pre-pregnancy, obstetric and delivery status in women with neuromyelitis optica spectrum disorder Ashtari, Fereshteh

44 C p.
artikel
68 Prevention of rebound effect after natalizumab withdrawal in multiple sclerosis. Study of two high-dose methylprednisolone schedules Fuentes-Rumí, Luna

44 C p.
artikel
69 RETRACTED: Retinal microvasculature alterations in neuromyelitis optica spectrum disorders before optic neuritis Kwapong, William Robert

44 C p.
artikel
70 Retraction notice to Retinal microvasculature alterations in neuromyelitis optica spectrum disorders before optic neuritis [Multiple sclerosis and related disorders 44 (2020) 102277] Kwapong, William Robert

44 C p.
artikel
71 “Rocking the boat” with a new drug for neuromyelitis optica spectrum disorder Levy, Michael

44 C p.
artikel
72 Saliva immunoglobulin free light chain analysis for monitoring disease activity and response to treatment in multiple sclerosis Lotan, Itay

44 C p.
artikel
73 Serial neuropsychological testing in MOG antibody-associated disease to improve understanding of outcomes Kornbluh, AB

44 C p.
artikel
74 Sex hormones secondary players in Susac's syndrome Alungulese, Anca Loredana

44 C p.
artikel
75 Spinal adhesive arachnoiditis mimicking sarcoid myelitis with nodular dural enhancement: A case report Clark, Grace

44 C p.
artikel
76 Subjective visual vertical and visual dependency in patients with multiple sclerosis Ulozienė, I.

44 C p.
artikel
77 Thalamic atrophy correlates with dysfunctional impulsivity in multiple sclerosis Joly, H.

44 C p.
artikel
78 The effectiveness of emotional wellness programs on mental health outcomes for adults with multiple sclerosis: a systematic review and meta-analysis Russell, R.D.

44 C p.
artikel
79 The increasing economic burden of multiple sclerosis by disability severity in Australia in 2017: Results from updated and detailed data on types of costs Ahmad, Hasnat

44 C p.
artikel
80 The ocrelizumab phase II extension trial suggests the potential to improve the risk: Benefit balance in multiple sclerosis. Baker, David

44 C p.
artikel
81 The relationship between aquaporin-4 antibody status and visual tract integrity in neuromyelitis optica spectrum disorders: A visual evoked potential study Barć, Krzysztof

44 C p.
artikel
82 The transitional phase of multiple sclerosis: Characterization and conceptual framework Kleiter, Ingo

44 C p.
artikel
83 The unresolved role of the neurologist in providing dietary advice to people with multiple sclerosis Russell, R.D.

44 C p.
artikel
84 Treatment of MOG-IgG-associated disorder with rituximab: An international study of 121 patients Whittam, Daniel H

44 C p.
artikel
85 Trends and characteristics of infection-related hospital admissions in multiple sclerosis patients in Southwest Finland in 2009–2018 Pirttisalo, Anna-Leena

44 C p.
artikel
86 Use of natural medicine and dietary supplements concomitant with conventional medicine among people with Multiple Sclerosis Bergien, S.O.

44 C p.
artikel
87 Vestibulo-ocular reflex involvement in childhood-onset multiple sclerosis Ertugrul, Gorkem

44 C p.
artikel
88 Whole transcriptome analysis of multiple Sclerosis patients reveals active inflammatory profile in relapsing patients and downregulation of neurological repair pathways in secondary progressive cases Nali, Luiz H.

44 C p.
artikel
                             88 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland